Pediatric Atopic Dermatitis Common Medications

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Your daily dose of the clinical news you may have missed.

June 11th 2025

Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announced

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

/ image credit Cathy Goldstein, MD Courtesy of Michigan Neuroscience Institute

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Huxley Medical's SANSA home sleep apnea test matched traditional PSG in accuracy and significantly simplifies OSA assessment and diagnosis for patients and HCPs.

June 4th 2025

Early Colorectal Cancer Screening at Ages 40-49 Reduces Long-Term Incidence and Mortality

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

Early Colorectal Cancer Screening at Ages 40-49 Reduces Long-Term Mortality and Incidence / image courtesy of National Taiwan University

FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions

As the incidence of young-onset colorectal cancer continues to rise, the findings from a large Taiwanese population-based study support lowering the age for initial screening.

June 17th 2025

Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose

The FDA assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 31, 2026.

Related Content

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Your daily dose of the clinical news you may have missed.

June 11th 2025

Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announced

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Huxley Medical's SANSA home sleep apnea test matched traditional PSG in accuracy and significantly simplifies OSA assessment and diagnosis for patients and HCPs.

June 4th 2025

Early Colorectal Cancer Screening at Ages 40-49 Reduces Long-Term Incidence and Mortality

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

FDA Accepts NDA for Anaphylm™, a Sublingual Epinephrine Film for Treatment of Severe Allergic Reactions

As the incidence of young-onset colorectal cancer continues to rise, the findings from a large Taiwanese population-based study support lowering the age for initial screening.

June 17th 2025